155.96
Finanzdaten der Transmedics Group Inc-Aktie (TMDX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
19.31%
96.85
|
81.17 | 66.43 | 52.47 | 41.55 |
Cost Of Revenue |
10.94%
36.89
|
33.25 | 25.77 | 15.72 | 12.79 |
Gross Profit |
25.12%
59.96
|
47.92 | 40.66 | 36.74 | 28.77 |
|
4.90%
47.54
|
45.32 | 69.00 | 37.65 | 30.86 |
Interest Income/Expense |
0.19%
3.598
|
3.605 | 3.59 | 2.505 | 1.091 |
Benefits Costs and Expenses |
9.24%
84.46
|
77.31 | 93.36 | 53.45 | 44.18 |
Costs And Expenses |
9.24%
84.46
|
77.31 | 93.36 | 53.45 | 44.18 |
Operating Income/Loss |
377.18%
12.42
|
2.603 | -28.34 | -0.906 | -2.089 |
Nonoperating Income/Loss |
102.22%
-0.028
|
1.26 | 1.406 | -0.074 | -0.536 |
Income/Loss From Continuing Operations Before Tax |
220.81%
12.39
|
3.863 | -26.93 | -0.98 | -2.625 |
Income Tax Expense/Benefit, Current |
216.67%
0.196
|
-0.168 | -1.507 | 0.021 | 0.011 |
Income Tax Expense/Benefit |
85.10%
0.196
|
1.315 | -1.507 | 0.021 | 0.011 |
Income/Loss From Continuing Operations After Tax |
378.69%
12.20
|
2.548 | -25.42 | -1.001 | -2.636 |
|
202.58%
12.20
|
4.031 | -25.42 | -1.001 | -2.636 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
76,353%
32.76
|
0.0429 | 32.61 | 32.55 | 32.26 |
Diluted Average Shares |
80,831%
34.68
|
0.0429 | 32.61 | 32.55 | 32.26 |
Basic Earnings Per Share |
208.33%
0.37
|
0.12 | -0.78 | -0.03 | -0.08 |
Diluted Earnings Per Share |
191.67%
0.35
|
0.12 | -0.78 | -0.03 | -0.08 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):